116 related articles for article (PubMed ID: 31840023)
1. Corrigendum: Design, Synthesis, and Biological Evaluation of (E)-N'-((1-Chloro-3,4-Dihydronaphthalen-2-yl)Methylene)Benzohydrazide Derivatives as Anti-prostate Cancer Agents.
Arjun HA; Elancheran R; Manikandan N; Lakshmithendral K; Ramanathan M; Bhattacharjee A; Lokanath NK; Kabilan S
Front Chem; 2019; 7():804. PubMed ID: 31840023
[TBL] [Abstract][Full Text] [Related]
2. Retraction: Corrigendum: Design, synthesis, and biological evaluation of (E)-N'-((1-chloro-3,4-dihydronaphthalen-2-yl)methylene)benzohydrazide derivatives as anti-prostate cancer agents.
Frontiers Editorial Office
Front Chem; 2023; 11():1332618. PubMed ID: 38025054
[TBL] [Abstract][Full Text] [Related]
3. Retraction: Design, synthesis, and biological evaluation of (E)-N'-((1-chloro-3,4-dihydronaphthalen-2-yl)methylene)benzohydrazide derivatives as anti-prostate cancer agents.
Frontiers Editorial Office
Front Chem; 2023; 11():1332615. PubMed ID: 38033470
[TBL] [Abstract][Full Text] [Related]
4. Design, Synthesis, and Biological Evaluation of (E)-N'-((1-Chloro-3,4-Dihydronaphthalen-2-yl)Methylene)Benzohydrazide Derivatives as Anti-prostate Cancer Agents.
Arjun HA; Elancheran R; Manikandan N; Lakshmithendral K; Ramanathan M; Bhattacharjee A; Lokanath NK; Kabilan S
Front Chem; 2019; 7():474. PubMed ID: 31355179
[TBL] [Abstract][Full Text] [Related]
5. Synthesis, Molecular Docking and Biological Evaluation of 2-Aryloxy-N-Phenylacetamide and N'-(2-Aryloxyoxyacetyl) Benzohydrazide Derivatives as Potential Antibacterial Agents.
Yele V; Azam MA; Wadhwani AD
Chem Biodivers; 2021 Apr; 18(4):e2000907. PubMed ID: 33576162
[TBL] [Abstract][Full Text] [Related]
6. Erratum: 2-Hydr-oxy-N'-[(E)-(3-hydr-oxy-2-naphth-yl)methyl-ene]benzohydrazide. Corrigendum.
Sun Y; Li HG; Wang X; Fu S; Wang D
Acta Crystallogr Sect E Struct Rep Online; 2009 Jul; 65(Pt 8):e21. PubMed ID: 21583291
[TBL] [Abstract][Full Text] [Related]
7. Erratum: 2-Hydr-oxy-N'-(4-isopropyl-cyclo-hexyl-carbon-yl)-3-methyl-benzohydrazide. Corrigendum.
Shu TP; Zhou Y; Wen JL; Chen SZ; Lei KW
Acta Crystallogr Sect E Struct Rep Online; 2009 May; 65(Pt 6):e16. PubMed ID: 21582974
[TBL] [Abstract][Full Text] [Related]
8. Exploring new selective 3-benzylquinoxaline-based MAO-A inhibitors: design, synthesis, biological evaluation and docking studies.
Khattab SN; Abdel Moneim SA; Bekhit AA; El Massry AM; Hassan SY; El-Faham A; Ali Ahmed HE; Amer A
Eur J Med Chem; 2015 Mar; 93():308-20. PubMed ID: 25707011
[TBL] [Abstract][Full Text] [Related]
9. Synthesis, magnetic and photomagnetic study of new iron(II) spin-crossover complexes with N₄O₂ coordination sphere.
Zhang L; Xu GC; Xu HB; Mereacre V; Wang ZM; Powell AK; Gao S
Dalton Trans; 2010 May; 39(20):4856-68. PubMed ID: 21491699
[TBL] [Abstract][Full Text] [Related]
10. Biological evaluation and in silico study of benzohydrazide derivatives as paraoxonase 1 inhibitors.
Korkmaz IN; Türkeş C; Demir Y; Öztekin A; Özdemir H; Beydemir Ş
J Biochem Mol Toxicol; 2022 Nov; 36(11):e23180. PubMed ID: 35916346
[TBL] [Abstract][Full Text] [Related]
11. Design, Synthesis and In Vitro Characterization of Novel Antimicrobial Agents Based on 6-Chloro-9
Bordei Telehoiu AT; Nuță DC; Căproiu MT; Dumitrascu F; Zarafu I; Ioniță P; Bădiceanu CD; Avram S; Chifiriuc MC; Bleotu C; Limban C
Molecules; 2020 Jan; 25(2):. PubMed ID: 31936505
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis and biological evaluation of 2-(4-phenylthiazol-2-yl) isoindoline-1,3-dione derivatives as anti-prostate cancer agents.
Saravanan K; Elancheran R; Divakar S; Anand SA; Ramanathan M; Kotoky J; Lokanath NK; Kabilan S
Bioorg Med Chem Lett; 2017 Mar; 27(5):1199-1204. PubMed ID: 28162857
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and biological evolution of hydrazones derived from 4-(trifluoromethyl)benzohydrazide.
Krátký M; Bősze S; Baranyai Z; Stolaříková J; Vinšová J
Bioorg Med Chem Lett; 2017 Dec; 27(23):5185-5189. PubMed ID: 29097168
[TBL] [Abstract][Full Text] [Related]
14. N'-[(E)-1-(5-Bromo-2-hy-droxy-phen-yl)ethyl-idene]-2-chloro-benzohydrazide.
Chang JG
Acta Crystallogr Sect E Struct Rep Online; 2011 Dec; 67(Pt 12):o3365. PubMed ID: 22199859
[TBL] [Abstract][Full Text] [Related]
15. Corrigendum: Ursolic Acid Hydrazide Based Organometallic Complexes: Synthesis, Characterization, Antibacterial, Antioxidant, and Docking Studies.
Jabeen M; Ahmad S; Shahid K; Sadiq A; Rashid U
Front Chem; 2018; 6():343. PubMed ID: 30140674
[TBL] [Abstract][Full Text] [Related]
16. In Silico Molecular Docking, Synthesis of 4-(4-benzoylaminophenoxy) Phenol Derivatives as Androgen Receptor Antagonists.
Elancheran R; Kabilan S; Kotoky J; Ramanathan M; Bhattacharjee A
Comb Chem High Throughput Screen; 2019; 22(5):307-316. PubMed ID: 31267866
[TBL] [Abstract][Full Text] [Related]
17. Design, Synthesis and Evaluation of Novel (E)-N'-((1-(4-chlorobenzyl)-1H-indol-3-yl)methylene)-2-(4-oxoquinazolin-3(4H)-yl)acetohydrazides as Antitumor Agents.
Dung DTM; Park EJ; Anh DT; Hai PT; Bao LQ; Ji AY; Kang JS; Tung TT; Han SB; Nam NH
Anticancer Agents Med Chem; 2022; 22(14):2586-2598. PubMed ID: 35040418
[TBL] [Abstract][Full Text] [Related]
18. Synthesis, Molecular Docking Study, and Biological Evaluation of New 4-(2,5-Dimethyl-1
Mahnashi MH; Koganole P; S R PK; Ashgar SS; Shaikh IA; Joshi SD; Alqahtani AS
Antibiotics (Basel); 2023 Apr; 12(4):. PubMed ID: 37107123
[TBL] [Abstract][Full Text] [Related]
19. N'-((2-(6-bromo-2-oxo-2H-chromen-3-yl)-1H-indol-3-yl)methylene)benzohydrazide as a probable Bcl-2/Bcl-xL inhibitor with apoptotic and anti-metastatic potential.
Kamath PR; Sunil D; Ajees AA; Pai KS; Biswas S
Eur J Med Chem; 2016 Sep; 120():134-47. PubMed ID: 27187865
[TBL] [Abstract][Full Text] [Related]
20. 3-Chloro-N'-[(2-hy-droxy-naphthalen-1-yl)methyl-idene]benzohydrazide.
Li TY; Li W
Acta Crystallogr Sect E Struct Rep Online; 2011 Jan; 67(Pt 2):o373. PubMed ID: 21523050
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
